Limit search to available items
Book Cover
E-book
Author Poynard, T. (Thierry)

Title Hepatitis C and B : management and treatment / Thierry Poynard
Edition 2nd ed
Published London : Taylor & Francis, 2004 (2005 printing)

Copies

Description 1 online resource (v, 168 pages) : color illustrations, color maps
Contents ""Book Cover""; ""Title""; ""Copyright""; ""Contents""; ""Introduction""; ""I Hepatitis C""; ""1. Natural History of Hepatitis C: Epidemiology""; ""2. Natural History of Hepatitis C: Hepatic Manifestations""; ""3. Natural of Hepatitis C: Extrahepatic Manifestations and Quality of Life""; ""4. Management Protocols in Chronic Hepatitis C""; ""5. Management of Relapsers and Nonresponders�Maintenance Therapy""; ""6. Management of Patients with Cirrhosis""; ""7. Management of Patients Coinfected by HCV and HIV""; ""8. Management of HCV Infection After Liver Transplantation""
""9. Management of Patients with Renal Disease""""10. Other Difficult-to-treat Populations""; ""11. Safety of Interferon, Pegylated Interferon (PEG-IFN) and Ribavirin""; ""12. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""13. What is the Cost-effectiveness of Combination Regiments?""; ""14. Management of Acute Hepatitis C""; ""15. Practical Guidelines for the Management of Hepatitis C""; ""16. New Drugs in Development""; ""References""; ""II Hepatitis B""; ""17. Natural History of Hepatitis B: Epidemiology""
""18. Natural History of Hepatitis B: Hepatic Manifestations""""19. Natural History of Hepatitis B: Extrahepatic Manifestations and Quality of Life""; ""20. Goal of Treatment in Chronic Hepatitis B""; ""21. Efficacy of Interferon and Pegylated Interferon (PEG-IFN)""; ""22. Efficacy of Lamivudine""; ""23. Comparison Between Lamivudine, Interferon and the Combination of Interferon and Lamivudine""; ""24. Safety of Lamivudine""; ""25. Efficacy of Adefovir""; ""26. Safety of Adefovir""; ""27. First-line Treatment of Chronic Hepatitis B: Adefovir, Lamivudine or Interferon?""
""28. New Drugs in Development""""29. Who Needs to be Treated and How to Explain the Goals to the Patient""; ""30. Management of Relapsers and Nonresponders""; ""31. Management of Patients Coinfected by HBV and HIV""; ""32. Management of Transplanted Patients Chronically Infected by HBV""; ""33. Cost-effectiveness of Treatment""; ""References""; ""III Biochemical Markers: An Alternative to Liver Biopsies""; ""34. Needle Biopsy of the Liver: Value and Limitations""; ""35. Advantage and Limits of Biochemical Markers""; ""References""
Summary Provides a practical explanation of the natural history and management of the diseases, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of biochemical markers and of the tgreatment of various difficult-to-treat patients
Notes "A Martin Dunitz book."
Previous ed. published as: Hepatitis C infection. London : Martin Dunitz, 2000
Bibliography Includes bibliographical references and index
Notes Print version record
Subject Hepatitis B -- Treatment
Hepatitis C -- Treatment
Interferon -- Therapeutic use
Biochemical markers -- Therapeutic use
Hepatitis, Viral.
Hepatitis B, Chronic -- drug therapy
Hepatitis C, Chronic -- drug therapy
Hepatitis B, Chronic -- complications
Hepatitis C, Chronic -- complications
FOREIGN LANGUAGE STUDY -- Spanish.
Hepatitis, Viral
Hepatitis C -- Treatment
Interferon -- Therapeutic use
Form Electronic book
Author Poynard, T. (Thierry). Hepatitis C infection
ISBN 0203357183
9780203357187